- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Diagnostic Imaging's A Look Ahead: Jan. 4, 2021, to Jan. 8, 2021
Here's what to expect this week on Diagnostic Imaging.
Welcome to a New Year at Diagnostic Imaging! In this week’s preview, here are some highlights of what you can expect to see coming soon:
With 2020 in the rear-view mirror, there is a great deal on the horizon for radiology. Editorial Board member Mina Makary, M.D., an interventional radiologist at Ohio State University Wexner Medical Center, shares his thoughts this week about what you can expect in the coming months. Keep an eye open for his insights.
In the meantime, take another look at 2020 end-of-year coverage.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Post-traumatic stress disorder (PTSD) can be the result of several factors – both physical and psychological – and it has been the focus of several research efforts in recent years. Still, little is understood about symptoms of this condition. In a new study, investigators from the University of California at San Diego have determined that brain volume measurement has the potential to be an early biomarker. Look for details on their findings soon.
For additional PTSD and traumatic brain injury coverage, click here.
As in year’s past, artificial intelligence (AI) continues its march toward being a much more integrated part of both research and clinical activities. This week, Frost & Sullivan analysts Suresh Kuppuswamy and Siddharth Shah offer perspectives about what vendors have done to further develop AI and enterprise imaging. Look for their insights about why AI and enterprise imaging "won" RSNA 2020.
For additional enterprise imaging coverage, click here.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
